-+ 0.00%
-+ 0.00%
-+ 0.00%

Abbott's Cologuard Plus Gets CE Mark for Colorectal Cancer Screening

PUBT·10/21/2026 11:06:54
Listen to the news
Abbott's Cologuard Plus Gets CE Mark for Colorectal Cancer Screening
  • Abbott’s Cologuard Plus noninvasive colorectal cancer screening test received CE marking under the EU’s In Vitro Diagnostic Regulation.
  • Launches are planned in selected European markets, with timing and availability varying by country.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Abbott Laboratories published the original content used to generate this news brief via PR Newswire (Ref. ID: 202610210700PR_NEWS_EUPR__DE_GE75830) on October 21, 2026, and is solely responsible for the information contained therein.